Therapy for pneumonitis and sialadenitis using CCR2-expressing T cells in mice
Author Information
Author(s): Hasegawa Hitoshi, Inoue Atsushi, Muraoka Masatake, Yamanouchi Jun, Miyazaki Tatsuhiko, Yasukawa Masaki
Primary Institution: Ehime University School of Medicine
Hypothesis
Can accumulating CCR2-expressing CD4+CD25+ regulatory T cells in target organs reduce the progression of autoimmune diseases in MRL/lpr mice?
Conclusion
The study demonstrated that CCR2-expressing Treg cells can significantly reduce the progression of pneumonitis and sialadenitis in MRL/lpr mice.
Supporting Evidence
- CCR2-Treg cells showed significantly reduced progression of pneumonitis and sialadenitis compared to Treg cells.
- MCP-1 expression increased with age in MRL/lpr mice, correlating with disease progression.
- The study suggests a new therapeutic approach for organ-specific autoimmune diseases.
Takeaway
Researchers found that special immune cells can help sick mice feel better by going to the right places in their bodies.
Methodology
The study involved transferring CCR2-expressing Treg cells into MRL/lpr mice and evaluating the effects on pneumonitis and sialadenitis.
Limitations
The study was conducted in a mouse model, which may not fully replicate human autoimmune diseases.
Participant Demographics
MRL/lpr mice, a strain that develops autoimmune diseases.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website